To confirm the role of SCG2 and CCL19 in CAVD and to clarify their distribution in various aortic valve cells, we analyzed single-cell sequencing data. The gene discussed is SCG2; the disease is congenital bilateral aplasia of vas deferens from CFTR mutation.